Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs): A Qualitative Analysis with Persons with HIV/HCV Co-infection Who Delay or Refuse Treatment

In the United States, approximately 25% of people with HIV (PWH) are co-infected with hepatitis C (HCV). Since 2014, highly effective and well-tolerated direct-acting antivirals (DAAs) have revolutionized HCV treatment. Uptake of DAAs by people with HIV/HCV co-infection has improved but remains subo...

Descripción completa

Detalles Bibliográficos
Autores principales: Brothers, Sarah, DiDomizio, Elizabeth, Nichols, Lisa, Brooks, Ralph, Villanueva, Merceditas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663279/
https://www.ncbi.nlm.nih.gov/pubmed/35776253
http://dx.doi.org/10.1007/s10461-022-03749-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663279/
https://www.ncbi.nlm.nih.gov/pubmed/35776253
http://dx.doi.org/10.1007/s10461-022-03749-8

Ejemplares similares